期刊文献+

普米克令舒氧气雾化吸入与沐舒坦口服联合治疗新生儿肺炎的疗效 认领

Combination of Pulmicort Ressu Oxygen Atomized Inhalation and Oral Ambroxol in the Treatment of Neonatal Pneumonia
在线阅读 下载PDF
收藏 分享 导出
摘要 目的研究氧气雾化吸入普米克令舒+口服沐舒坦在新生儿肺炎中的可行性。方法研究在依据纳入标准、排除标准的基础方便选取新生儿肺炎患儿80例,收治时间为2018年10月—2019年10月。随机分为参照组(n=40)经口服沐舒坦进行治疗,观察组(n=40)经氧气雾化吸入普米克令舒+口服沐舒坦进行治疗。对患儿的临床治疗效果、炎症指标分析对比。结果观察组的总有效率(97.5%)较参照组(77.5%)高,差异有统计学意义(χ^2=7.314,P<0.05)。治疗后患儿上述指标均下降[观察组IL-2(40.12±1.52)ng/L、IL-6(23.24±0.24)ng/L、IL-10(4.02±0.25)ng/L,优于对照组的(45.25±0.16)ng/L、(33.42±0.10)ng/L、(8.79±0.10)ng/L],且治疗后观察组的数值均较参照组低,差异有统计学意义(t=12.310,P=0.010;t=13.010,P<0.001;t=13.45,P<0.001)。观察组患儿发热、咳嗽、呼吸急促、肺部啰音消失时间[(3.24±0.11)d、(4.17±0.24)d、(3.07±0.35)d、(4.53±0.25)d]较参照组短[(6.38±0.15)d、(7.80±0.15)d、(7.68±0.11)d、(8.87±0.18)d],差异有统计学意义(t=12.450,P<0.001;t=13.320,P<0.001;t=11.210,P<0.001;t=12.420,P=0.010)。结论对新生儿肺炎行氧气雾化吸入普米克令舒+口服沐舒坦治疗,对患儿炎症反应有改善效果,疗效确切。 Objective To study the feasibility of oxygen atomized inhalation of Pulmicort Resul and oral mucosol in neonatal pneumonia.Methods A total of 80 children with neonatal pneumonia were convenient selected in the study based on the inclusion and exclusion criteria.The admission period was from October 2018 to October 2019.Randomly divided into the reference group(n=40)received oral mucosulfan for treatment,and the observation group(n=40)received oxygen atomization inhalation of Pulmicort Resul+oral mucosulfan for treatment.Analysis and comparison of clinical treatment effects and inflammation indicators in children.Results The total effective rate(97.5%)of the observation group was higher than that of the reference group(77.5%),which was statistically significant(χ^2=7.314,P<0.05).After treatment,the above indicators of the children were decreased[in the observation group,IL-2(40.12±1.52)ng/L,IL-6(23.24±0.24)ng/L,IL-10(4.02±0.25)ng/L,better than the control group(45.25±0.16)ng/L,(33.42±0.10)ng/L,(8.79±0.10)ng/L],and the values of the observation group after treatment were lower than those of the reference group,the difference was statistically significant(t=12.310,P=0.010;t=13.010,P<0.001;t=13.450,P<0.001).The observation group in fever,cough,shortness of breath,and disappearance of lung rales were(3.24±0.11)d,(4.17±0.24)d,(3.07±0.35)d,(4.53±0.25)d,compared to the reference group was short[(6.38±0.15)d,(7.80±0.15)d,(7.68±0.11)d,(8.87±0.18)d],the difference was statistically significant(t=12.450,P<0.001;t=13.320,P<0.001;t=11.210,P<0.001;t=12.420,P=0.010).Conclusion The treatment of neonatal pneumonia with oxygen atomized inhalation of Pulmicort Resul and oral mucosulfan can improve the inflammatory response in children with definite curative effect.
作者 胡冰玉 叶立伟 HU Bing-yu;YE Li-wei(Department of Pediatrics,Daqing Longnan Hospital(The Fifth Affiliated Hospital of Qiqihar Medical College),Daqing,Heilongjiang Province,163453 China)
出处 《中外医疗》 2020年第27期77-79,共3页 China & Foreign Medical Treatment
关键词 氧气雾化吸入 普米克令舒 沐舒坦 新生儿肺炎 Oxygen atomized inhalation Pulmicort Resul Mucosol Neonatal pneumonia
  • 相关文献

二级参考文献54

共引文献46

必果论文
维普数据出版直通车
投稿分析
职称考试

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈